AUTHOR=Li He , Li Li-li , Wang Jian , Wang Yong-qiang , Wang Lan , Yuan Lan , Chen Wen-ting , Song Jian-gang 

TITLE=Effect of electroacupuncture on the repair of stress ulcer injury in neurocritical patients: A randomized clinical trial

JOURNAL=Frontiers in Medicine

VOLUME=Volume 9 - 2022

YEAR=2022

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.1001584

DOI=10.3389/fmed.2022.1001584

ISSN=2296-858X

ABSTRACT=Background: Stress ulcer (SU) is one of the main causes of prolonged hospital stay, poor prognosis, and increased mortality in critically ill patients. This study aimed to investigate the effect of electroacupuncture (EA) on SU in patients with severe neurological diseases and explore its possible mechanisms.
Methods: Taking SU patients in adult neurocritical care as the research object, they were randomly divided into the EA group and the control group. Through the perioperative EA intervention, the following indicators were documented: main observation indicator (the effective rate of SU treatment), secondary observation indicators (gastric juice pH, gastric juice occult blood test, and stool occult blood test), related mechanisms (repair factors TFF2, VEGF, and HSP70), complications during hospitalization, and ICU stay time.
Results: Compared with the control treatment, EA increased the effective rate of SU treatment (85.4% for EA group, 57.5% for control group, Risk difference: 27.9% (95% CI: 8.3%-45.1%); P < 0.01). EA increased the success rate of gastric juice pH treatment on days 1, 2, and 3 (P < 0.01 for day 1, P < 0.05 for days 2 and 3). EA lowered the positive rate of gastric occult blood test on days 1 and 3 (all P < 0.05) and the positive rate of fecal occult blood test on day 3 (P < 0.05). EA also reduced the ICU stay time (P < 0.01) and total hospitalization time (P < 0.05). Compared to day 0, all serum repair factors (VEGF, HSP70, and TTF2) of both groups significantly increased on days 1, 3, and 5 (all P < 0.01). Compared with the control group, VEGF in the EA group was increased on days 3 and 5 (all P < 0.01); HSP70 was increased on days 1, 3, and 5 (P < 0.05 for day 1, P < 0.01 for days 3 and 5); and TTF2 was increased on days 1, 3, and 5 (all P < 0.01).
Conclusion: EA promoted the repair of SU damage in severe neurological disease, and its effect was related to enhancing the expression of gastric mucosal repair factors.
Clinical Trial Registration: [www.chictr.org.cn/showprojen.aspx?proj=127012], identifier [ChiCTR2100046701].